JBS N.V.
NYSE:JBSPackaged Foods
-$0.34 today
- Market cap
- $26.66B
- Beta
- 0.17
- P/E (TTM)
- 6.9
- EPS (TTM)
- $8.91
- Dividend yield
- 8.41%
Volume 9.80M
Average 6.65M
JBS Net Income
Bottom-line profit after all expenses, interest, and taxes.
JBS N.V.NYSE: JBS
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income declines year over year
Q3 FY2026 net income of $188.86M fell 93.9% year over year, behind the -47.5% change in trailing-twelve-month net income. Over 3 fiscal years it compounded at -11.2% a year.
Context
- Net income amounted to 2.4% of revenue in FY2025, unchanged from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -93.9% toward the trailing-twelve-month pace of -47.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Net Income history
BRL · from the income statement
- Latest · FY2025
- 11.1B BRL
- Year-over-year change
- +15.4%
- 4-year CAGR
- -15.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.1B | +15.4% |
| FY2024 | 2024-12-31 | 9.62B | +1006.3% |
| FY2023 | 2023-12-31 | (1.06B) | -106.7% |
| FY2022 | 2022-12-31 | 15.85B | -25.4% |
| FY2021 | 2021-12-31 | 21.24B | — |
Net Income vs competitors
How JBS compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -47.5% is the 4th highest of 6, against a peer median of -4.4%.
- Net income amounts to 1.7% of revenue for JBS, versus a peer median of 3.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
JBSJBS N.V. | LTM Jun 2026 | R$6.41B BRL | -47.5% | -11.2% | 1.7% |
| LTM Sep 2026 | $899M USD | +4.1% | +4.3% | 5.9% | |
| LTM Oct 2026 | $552M USD | +38.7% | -5.1% | 5.3% | |
| LTM Jun 2026 | $545.61M USD | -55.9% | +13.2% | 3.0% | |
| LTM Oct 2026 | $453M USD | -4.4% | — | 0.8% | |
| LTM Jul 2026 | $342.65M USD | -54.6% | -21.8% | 2.8% | |
| Peer median (excluding JBS) | — | -4.4% | -0.4% | 3.0% | |
Competitors are the stored peer set for JBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 362.5B | 383.97B | 363.82B | 416.95B | 471.14B |
| Cost of Revenue | 294.01B | 322.93B | 324.17B | 354.18B | 410.82B |
| Gross Profit | 68.49B | 61.04B | 39.65B | 62.77B | 60.33B |
| Gross Margin | 18.9% | 15.9% | 10.9% | 15.1% | 12.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 29.77B | 34.95B | 33.98B | 36.99B | 37.78B |
| Operating Expenses | 35.14B | 35.75B | 34.35B | 39.01B | 37.7B |
| Depreciation & Amortization | 9.03B | 10.05B | 10.38B | 11.95B | 12.63B |
| EBITDA | 42.68B | 35.94B | 16.34B | 37.65B | 36.21B |
| EBITDA Margin | 11.8% | 9.4% | 4.5% | 9.0% | 7.7% |
| Operating Income | 33.35B | 25.29B | 5.3B | 23.76B | 22.63B |
| Operating Margin | 9.2% | 6.6% | 1.5% | 5.7% | 4.8% |
| Interest Income | 144.33M | 268.42M | 326.44M | 453.73M | 2.3B |
| Interest Expense | 975.16M | 1.34B | 1.73B | 1.65B | 9.18B |
| Other Income / Expenses | (5.13B) | (6.5B) | (6.7B) | (8.94B) | (8.23B) |
| Income Before Tax | 28.22B | 18.79B | (1.4B) | 14.82B | 14.4B |
| Pre-Tax Margin | 7.8% | 4.9% | -0.4% | 3.6% | 3.1% |
| Income Tax Expense | 6.93B | 2.17B | (668.94M) | 4.12B | 2.17B |
| Net Income | 21.24B | 15.85B | (1.06B) | 9.62B | 11.1B |
| Net Margin | 5.9% | 4.1% | -0.3% | 2.3% | 2.4% |
| EPS (Basic) | 8.58 | 7.09 | (0.48) | 0.80 | 10.41 |
| EPS (Diluted) | 8.58 | 7.09 | (0.48) | 0.80 | 10.41 |
| Weighted Avg Shares | 2.48B | 2.25B | 2.22B | 2.22B | 1.07B |
| Weighted Avg Shares (Diluted) | 2.48B | 2.25B | 2.22B | 2.22B | 1.07B |
JBS N.V.
NYSE:JBS
Intrinsic Alpha fair value
Locked
Current Price
$12.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.